Acadia Pharmaceuticals Insider Sells Nearly Half Their Shares
James Kihara, Principal Accounting Officer of Acadia Pharmaceuticals (ACAD), sold nearly half of his direct shares in the company on June 26, 2026. The transaction involved 11,421 shares valued at approximately $298,000 and marked a significant reduction in Kihara's holdings.
Tickers: $ACAD